Concepedia

Author

J. Rifón

Clinica Universidad de NavarraORCID

Also Known As

Carmen D’Amelio, J J Rifon, J Rifon, J Rifón, J. Baro, J. J. Rifón, J. Rifon, J. Rifón, Jose J. Rifon, Jose Rifon

132

Publications

3.1K

Citations

26

H-Index

71

Concepts

All Affiliations

Clinica Universidad de NavarraUniversidad de NavarraHospital de Sant PauHospital Clínico Universitario de ValenciaCentro de Investigación Biomédica en Red de Cáncer
JR

About

J. Rifón is an author at Clinica Universidad de Navarra specializing in medicine, hematology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

20

1.3K

2

Health Sciences

2

2

25

3

Public Health

2

2

96

4

Natural Sciences

1

1

55

5

Blood Transplantation

1

1

85

J. Rifón

×

41

Publications

2.8K

Citations

26

H-Index

YearCitations

Epigenetic Silencing of the Tumor Suppressor MicroRNA <i>Hsa-miR-124a</i> Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia

Xabier Agirre, Amaia Vilas‐Zornoza, Antonio Jiménez‐Velasco,

Cancer Research

2009

300

Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 Patients From the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative Group

Anna Sureda, R. Arranz, A Iriondo,

Journal of Clinical Oncology

2001

230

Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse

Anna Sureda, M. Constans, A Iriondo,

Annals of Oncology

2005

220

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

Ion Cristóbal, Francisco J. Blanco, Laura García-Ortí,

Blood

2009

178

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial

Josè Antonio Pérez-Simón, Olga López‐Villar, Enrique J. Andreu,

Haematologica

2011

173

BCR-ABL Induces the Expression of Skp2 through the PI3K Pathway to Promote p27Kip1 Degradation and Proliferation of Chronic Myelogenous Leukemia Cells

Enrique J. Andreu, Elisa Lledó, Enric Poch,

Cancer Research

2005

153

BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors

MD Caballero, Vicente Rubio, J. Rifón,

Bone Marrow Transplantation

1997

152

High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience

José Rodríguez, Marı́a Dolores Caballero, Antonio Gutiérrez,

Annals of Oncology

2003

129

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

Jesús F. San Miguel, Juan José Lahuerta, Ramón García‐Sánz,

The Hematology Journal

2000

117

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry

Adrían Alegre, J Díaz-Mediavilla, Jesús F. San Miguel,

Bone Marrow Transplantation

1998

85

Page 1